Background: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are central nervous system (CNS) inflammatory demyelinating disorders. It is clinically important to distinguish MS from NMOSD, as treatment and prognosis differ. Brainstem involvement is common in both disorders. Purpose: To investigate whether the patterns of brainstem atrophy on volumetric analysis in MS and NMOSD were different and correlated with clinical disability. Study Type: Case–control cross-sectional study. Subjects: In all, 17 MS, 13 NMOSD, and 18 healthy control (HC) subjects were studied. Field Strength/Sequence: T1-weighted and T2w spin-echo images were acquired with a 3T scanner. Assessment: Semiautomated segmentation and volumetric meas...
Background and purposeStudies on cortical involvement and its relationship with cognitive function i...
BACKGROUND: Brain stem lesions are common in patients with acute disseminated encephalomyelitis (ADE...
As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investi...
BACKGROUND: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are central ...
Introduction: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are the mo...
Objective: To investigate spinal cord and brain atrophy in neuromyelitis optica (NMO), and its relat...
OBJECTIVE: To investigate the longitudinal spinal cord and brain changes in neuromyelitis optica (NM...
Brain regions responsible for cognitive dysfunction in MS and neuromyelitis optica spectrum disorder...
OBJECTIVE--To compare the abnormalities shown by magnetic resonance imaging of the brain in three cl...
BACKGROUND AND PURPOSE: Progressive brain atrophy is a well-known feature of multiple sclerosis (MS)...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Objective: To investigate cognitive function and MRI-measured brain volume and cortical thickness in...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
Introduction: Multiple sclerosis (MS) is a chronic neurological disease in which demyelination and l...
Background and purposeStudies on cortical involvement and its relationship with cognitive function i...
BACKGROUND: Brain stem lesions are common in patients with acute disseminated encephalomyelitis (ADE...
As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investi...
BACKGROUND: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are central ...
Introduction: Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are the mo...
Objective: To investigate spinal cord and brain atrophy in neuromyelitis optica (NMO), and its relat...
OBJECTIVE: To investigate the longitudinal spinal cord and brain changes in neuromyelitis optica (NM...
Brain regions responsible for cognitive dysfunction in MS and neuromyelitis optica spectrum disorder...
OBJECTIVE--To compare the abnormalities shown by magnetic resonance imaging of the brain in three cl...
BACKGROUND AND PURPOSE: Progressive brain atrophy is a well-known feature of multiple sclerosis (MS)...
Objective: Gray matter (GM) atrophy occurs in all multiple sclerosis (MS) phenotypes. We investigate...
Background: In multiple sclerosis (MS), brain atrophy depicted by magnetic resonance imaging reflect...
Objective: To investigate cognitive function and MRI-measured brain volume and cortical thickness in...
Background Brain atrophy is a well-accepted imaging biomarker of multiple sclerosis (MS) that partia...
Introduction: Multiple sclerosis (MS) is a chronic neurological disease in which demyelination and l...
Background and purposeStudies on cortical involvement and its relationship with cognitive function i...
BACKGROUND: Brain stem lesions are common in patients with acute disseminated encephalomyelitis (ADE...
As atrophy represents the most relevant driver of progression in multiple sclerosis (MS), we investi...